YI
111, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CN
$3.51
+5.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.93x
- Price / sales
- 0.02x
- Price / cash flow
- -2.43x
Enterprise value
- Enterprise value
- $49.1M
- EV / sales
- 0.03x
- EV / EBITDA
- -19.61x
- EV / EBIT
- -12.28x
- Market cap
- $30.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026